CA2408610A1 - Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions - Google Patents

Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions Download PDF

Info

Publication number
CA2408610A1
CA2408610A1 CA002408610A CA2408610A CA2408610A1 CA 2408610 A1 CA2408610 A1 CA 2408610A1 CA 002408610 A CA002408610 A CA 002408610A CA 2408610 A CA2408610 A CA 2408610A CA 2408610 A1 CA2408610 A1 CA 2408610A1
Authority
CA
Canada
Prior art keywords
composition
compositions
present
methylsulfonylmethane
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002408610A
Other languages
English (en)
Inventor
Matthew Thomas Heisey
Kenneth Norman Kern
Kris Eugene Spence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SD IP Holdings Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/759,965 external-priority patent/US20020132780A1/en
Application filed by Individual filed Critical Individual
Publication of CA2408610A1 publication Critical patent/CA2408610A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des compositions, des nécessaires et des méthodes servant au traitement d'un dysfonctionnement articulaire, d'un dysfonctionnement osseux, et/ou d'une inflammation. Les compositions de l'invention sont utiles pour des mammifères souffrant de pathologies articulaires douloureuses ou débilitantes, de maladies osseuses ou de syndromes inflammatoires, et conviennent particulièrement pour des mammifères atteints ou susceptibles d'être atteints du diabète, ainsi que pour des personnes désirant ou nécessitant des compositions de protection des cartilages dosées sans inconvénient présentant une basse teneur en glucides, une faible valeur énergétique et/ou un faible indice glycémique. En particulier, les compositions de l'invention contiennent: a) un agent de protection des cartilages sélectionné dans le groupe constitué par de la gélatine, du cartilage, des aminosucres, des glycosaminoglycanes, un méthylsulfonylméthane, des précurseurs de méthylsulfonylméthane, S-adénosylméthionine, et leur mélanges; b) un édulcorant autre que le glucose, le dextrose, le saccharose et le fructose; et c) de l'eau pour au moins environ 10 % en poids de la composition. Dans une autre forme de réalisation, les compositions de l'invention comprennent: a) un agent de protection des cartilages sélectionné dans le groupe constitué par de la gélatine, du cartilage, des aminosucres, des glycosaminoglycanes, un méthylsulfonylméthane, des précurseurs de méthylsulfonylméthane, S-adénosylméthionine, leurs sels et mélanges; b) un édulcorant autre que le glucose, le dextrose, le saccharose et le fructose; ladite composition étant sensiblement exempte d'aspartame. D'autres compositions de l'invention contiennent un agent de protection des cartilages sélectionné dans le groupe constitué par de la gélatine, du cartilage, des aminosucres, des glycosaminoglycanes, un méthylsulfonylméthane, des précurseurs de méthylsulfonylméthane, S-adénosylméthionine, et leur mélanges, et présentent une basse teneur en glucides.
CA002408610A 2000-06-02 2001-06-01 Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions Abandoned CA2408610A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
US09/586,514 2000-06-02
US09/759,965 US20020132780A1 (en) 2001-01-12 2001-01-12 Low carbohydrate compositions, kits thereof, and methods of use
US09/759,965 2001-01-12
PCT/US2001/017716 WO2001093831A2 (fr) 2000-06-02 2001-06-01 Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions

Publications (1)

Publication Number Publication Date
CA2408610A1 true CA2408610A1 (fr) 2001-12-13

Family

ID=27079730

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002408610A Abandoned CA2408610A1 (fr) 2000-06-02 2001-06-01 Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions

Country Status (8)

Country Link
EP (1) EP1289532A2 (fr)
JP (1) JP2003535120A (fr)
CN (1) CN1438892A (fr)
AU (1) AU2001269730A1 (fr)
BR (1) BR0111292A (fr)
CA (1) CA2408610A1 (fr)
MX (1) MXPA02011939A (fr)
WO (1) WO2001093831A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393062A (zh) * 2005-11-23 2013-11-20 可口可乐公司 具有改良时间变化形廓及／或风味形廓的天然高效甜味剂组成物与其调和方法和用途

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431937B2 (en) * 2001-03-30 2008-10-07 L'oreal, S.A. Compositions comprising at least one aminated C5-C7 saccharide unit, and their use for the protection and/or repair of keratinous fibers
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
AU2003903037A0 (en) * 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
US20100035992A1 (en) * 2008-03-11 2010-02-11 Rajiv Bhushan Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies
KR101314322B1 (ko) * 2009-09-28 2013-10-02 박유신 관절 및 결체조직 관련 질병의 치료 및 예방을 위한 약학 조성물
WO2014152789A1 (fr) 2013-03-15 2014-09-25 New York University Boisson contenant du citrate
WO2015159155A2 (fr) * 2014-04-14 2015-10-22 Methylation Sciences International Srl Nouvelles formulations d'adémétionine
JP6528588B2 (ja) * 2014-08-19 2019-06-12 大正製薬株式会社 固形製剤
KR101957502B1 (ko) * 2018-08-17 2019-03-12 이승훈 메틸설포닐메탄을 함유하는 비만, 지방간 및 당뇨병 예방 또는 개선용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
JP4070844B2 (ja) * 1997-08-20 2008-04-02 株式会社ヤクルト本社 マグネシウム含有経口組成物
JP2971855B1 (ja) * 1998-06-22 1999-11-08 明治乳業株式会社 風味のよいアミノ酸含有食品の製造方法
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
JP4300652B2 (ja) * 1998-09-21 2009-07-22 大正製薬株式会社 経口用固形製剤
US5993880A (en) * 1998-10-01 1999-11-30 Kraft Foods Inc. Non-staining, acid-stable, cold-water-soluble, edible green color and compositions for preparing acidic foods and beverages
JP2000175648A (ja) * 1998-12-11 2000-06-27 Sanei Gen Ffi Inc 乳清ミネラルを含有する甘味組成物
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
JP2000281562A (ja) * 1999-03-30 2000-10-10 Taisho Pharmaceut Co Ltd ゲル状組成物
JP2000290199A (ja) * 1999-03-31 2000-10-17 Taisho Pharmaceut Co Ltd 経口用医薬組成物
JP4173606B2 (ja) * 1999-06-18 2008-10-29 サントリー株式会社 低酸性飲料の製造方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393062A (zh) * 2005-11-23 2013-11-20 可口可乐公司 具有改良时间变化形廓及／或风味形廓的天然高效甜味剂组成物与其调和方法和用途
CN103393062B (zh) * 2005-11-23 2016-08-31 可口可乐公司 具有改良时间变化形廓及／或风味形廓的天然高效甜味剂组成物与其调和方法和用途

Also Published As

Publication number Publication date
CN1438892A (zh) 2003-08-27
AU2001269730A1 (en) 2001-12-17
JP2003535120A (ja) 2003-11-25
MXPA02011939A (es) 2003-04-22
EP1289532A2 (fr) 2003-03-12
WO2001093831A2 (fr) 2001-12-13
WO2001093831A3 (fr) 2002-04-25
BR0111292A (pt) 2003-06-10

Similar Documents

Publication Publication Date Title
US20020132780A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
US20030069202A1 (en) Compositions, kits, and methods for promoting defined health benefits
US6413558B1 (en) Compositions, kits, and methods for providing and maintaining energy and metal alertness
CA2463668C (fr) Compositions et trousses comprenant un compose de bore defini, leurs procedes de preparation, leur utilisation et administration
US20020187219A1 (en) Low glycemic response compositions
CN1220583A (zh) 对含肌酸的组合物或涉及该组合物的改善
WO2001093831A2 (fr) Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions
CA2408611A1 (fr) Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages
WO2001093832A2 (fr) Compositions aqueuses de protection des cartilages présentant des contraintes posologiques déterminées pour une administration efficace
US20060246200A1 (en) Hydroxyapatite in aqueous solution for bone health
CA2408612A1 (fr) Compositions chondroprotectrices aqueuses dotees de limites de ph definies a des fins d'administration efficace
HK1129543A (en) Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
CN101133834A (zh) 提供和维持能量及精神灵敏性的组合物、试剂盒及方法
MXPA98009764A (en) Improvements in, or related to, compositions containing creat
HK1019694B (en) Improvements in or relating to compositions containing creatine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead